BI 885578, a novel IGF1R/INSR tyrosine kinase inhibitor...

  • Main
  • 2015 / 10
  • BI 885578, a novel IGF1R/INSR tyrosine kinase inhibitor...
Molecular Cancer Therapeutics 2015 / 10

BI 885578, a novel IGF1R/INSR tyrosine kinase inhibitor with pharmacokinetic properties that dissociate anti-tumor efficacy and perturbation of glucose homeostasis

Sanderson, M. P., Apgar, J., Garin-Chesa, P., Hofmann, M. H., Kessler, D., Quant, J., Savchenko, A., Schaaf, O., Treu, M., Tye, H., Zahn, S. K., Zoephel, A., Haaksma, E., Adolf, G. R., Kraut, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-15-0539
Date:
October, 2015
File:
PDF, 2.14 MB
english, 2015
Conversion to is in progress
Conversion to is failed